CIPO Patents = 1

EPO Patents = 2

Forward Citations = 19

Loading Chart...

2 inventors (with patents filed for the assignee):

Min Zhong (12 out of 41 patents)

Leping Li (12 out of 27 patents)

Min Zhong (0 patent)

12 patents: Sort by Forward Citations

1. 9309260 - Inhibitors of hepatitis C virus (2016-04-12),

2. 9150554 - Fused ring inhibitors of hepatitis C (2015-10-06),

3. 9120779 - Inhibitors of HCV NS5A (2015-09-01),

4. 9085587 - Inhibitors of hepatitis C virus (2015-07-21),

5. 8999967 - Tricyclic fused ring inhibitors of hepatitis C (2015-04-07),

6. 8921369 - Inhibitors of HCV NS5A (2014-12-30),

7. 8877707 - Inhibitors of HCV NS5A (2014-11-04),

8. 8865756 - Inhibitors of HCV NS5A (2014-10-21),

9. 8822520 - Substituted bicyclic HCV inhibitors (2014-09-02),

10. 8709999 - Substituted bicyclic HCV inhibitors (2014-04-29),

11. 8618151 - Inhibitors of HCV NS5A (2013-12-31),

12. 8614207 - Inhibitors of hepatitis C virus (2013-12-24),

Presidio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of novel treatments for viral infections. With a strong emphasis on research and innovation, Presidio Pharmaceuticals aims to provide effective therapies for diseases such as HIV, hepatitis C, and respiratory syncytial virus (RSV). The company's mission is to improve patient outcomes and address unmet medical needs in infectious diseases through its groundbreaking drug discovery programs and strategic partnerships.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#371 in San Francisco, CA

#5,885 in California

#24,829 in US

#46,724 in the World

San Francisco, CA, United States of America

Presidio Pharmaceuticals, Inc.

Forward Citations = 19

2 inventors:

Min Zhong (12 out of 41 patents)

Leping Li (12 out of 27 patents)

Min Zhong (0 patent)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com